Stockhub

Cosmo Pharmaceuticals N.V.: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

22 September 2022

  • curprev 22:0622:06, 22 September 2022 95.149.241.133 talk 1,728 bytes +1,728 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Cosmo Pharmaceuticals N.V., a specialty pharmaceutical company, focuses on the development and commercialization products for gastroenterology and endoscopy worldwide. It offers Lialda/Mezavant/Mesavancol and UCERIS/Cortiment, an oral tablet formulation for remission in active, mild to moderate ulcerative colitis; GI Genius, a system that uses artificial intelligence to detect colorectal polyps; and Methylene Blue MMX, diag..."
Retrieved from "https://stockhub.co/research/Cosmo_Pharmaceuticals_N.V."